Huafang Li

4.0k total citations
82 papers, 2.0k citations indexed

About

Huafang Li is a scholar working on Psychiatry and Mental health, Molecular Biology and Pharmacology. According to data from OpenAlex, Huafang Li has authored 82 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Psychiatry and Mental health, 25 papers in Molecular Biology and 12 papers in Pharmacology. Recurrent topics in Huafang Li's work include Schizophrenia research and treatment (27 papers), Tryptophan and brain disorders (12 papers) and Treatment of Major Depression (10 papers). Huafang Li is often cited by papers focused on Schizophrenia research and treatment (27 papers), Tryptophan and brain disorders (12 papers) and Treatment of Major Depression (10 papers). Huafang Li collaborates with scholars based in China, United States and Hong Kong. Huafang Li's co-authors include Yufeng Zheng, Ling Qin, Hongtao Yang, Xiang Wang, Feiyu Zhou, Kejin Qiu, Niufan Gu, Yifeng Shen, Guoyin Feng and Shunying Yu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biomaterials.

In The Last Decade

Huafang Li

74 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huafang Li China 20 617 528 408 394 356 82 2.0k
Chang‐Uk Lee South Korea 30 295 0.5× 145 0.3× 87 0.2× 636 1.6× 626 1.8× 95 3.1k
Lishu Zhang China 21 179 0.3× 396 0.8× 111 0.3× 89 0.2× 217 0.6× 41 1.3k
Dongdong Qin China 30 167 0.3× 228 0.4× 113 0.3× 63 0.2× 745 2.1× 123 3.0k
Yasuhisa Sakurai Japan 32 615 1.0× 214 0.4× 186 0.5× 196 0.5× 338 0.9× 167 4.0k
Samuel Law Canada 29 266 0.4× 135 0.3× 122 0.3× 345 0.9× 733 2.1× 98 3.3k
Yingdong Zhang China 36 79 0.1× 442 0.8× 316 0.8× 205 0.5× 1.1k 3.0× 152 4.5k
Éric Fréchette Canada 13 304 0.5× 109 0.2× 150 0.4× 185 0.5× 298 0.8× 33 2.9k
Yue Lan China 28 140 0.2× 507 1.0× 71 0.2× 101 0.3× 476 1.3× 196 2.7k
Xinglong Yang China 25 269 0.4× 281 0.5× 99 0.2× 54 0.1× 592 1.7× 139 2.2k
Xianglan Liu China 28 65 0.1× 124 0.2× 95 0.2× 145 0.4× 623 1.8× 88 2.4k

Countries citing papers authored by Huafang Li

Since Specialization
Citations

This map shows the geographic impact of Huafang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huafang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huafang Li more than expected).

Fields of papers citing papers by Huafang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huafang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huafang Li. The network helps show where Huafang Li may publish in the future.

Co-authorship network of co-authors of Huafang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Huafang Li. A scholar is included among the top collaborators of Huafang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huafang Li. Huafang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Yue, et al.. (2025). The genetic association between major depressive disorder and coronary heart disease. Acta Neuropsychiatrica. 37. e49–e49.
2.
Chen, Youjun, Wanying Wang, Jingjing Huang, et al.. (2024). The atypical antipsychotics and sexual dysfunction: a pharmacovigilance-pharmacodynamic study. Frontiers in Pharmacology. 15. 1423075–1423075. 5 indexed citations
3.
Shen, He, Yue Shi, Dan Liu, et al.. (2023). Does decreased autophagy and dysregulation of LC3A in astrocytes play a role in major depressive disorder?. Translational Psychiatry. 13(1). 362–362. 6 indexed citations
4.
5.
Li, Yuanyuan, et al.. (2021). Association Study of Polymorphisms in Neuronal Nicotinic Acetylcholine Receptor Subunit Genes With Schizophrenia in the Han Chinese Population. Psychiatry Investigation. 18(10). 943–948. 1 indexed citations
6.
He, Shen, Tian Li, Yue Shi, et al.. (2021). Sex differences between serum total bilirubin levels and cognition in patients with schizophrenia. BMC Psychiatry. 21(1). 396–396. 6 indexed citations
7.
Xu, Qingqing, Mo Li, Shengying Qin, et al.. (2020). Two Novel Loci of RELN Associated With Antipsychotics Response in Chinese Han Population. Frontiers in Pharmacology. 11. 7–7. 5 indexed citations
8.
Shen, He, Yi Wen, Ying Xie, et al.. (2019). Co-Expression Network Analysis Revealed That the ATP5G1 Gene Is Associated With Major Depressive Disorder. Frontiers in Genetics. 10. 703–703. 12 indexed citations
9.
Zhang, Fan, et al.. (2018). Population Pharmacokinetics, Safety and Tolerability of Extended-Release Bupropion and Its Three Metabolites in Chinese Healthy Volunteers. European Journal of Drug Metabolism and Pharmacokinetics. 44(3). 339–352. 5 indexed citations
10.
11.
Li, Huafang, et al.. (2018). PE17 protein from Mycobacterium tuberculosis enhances Mycobacterium smegmatis survival in macrophages and pathogenicity in mice. Microbial Pathogenesis. 126. 63–73. 19 indexed citations
12.
Wang, Jiali, Yuanhao Wu, Huafang Li, et al.. (2017). Magnesium alloy based interference screw developed for ACL reconstruction attenuates peri-tunnel bone loss in rabbits. Biomaterials. 157. 86–97. 105 indexed citations
13.
Shen, He, Xiaohua Liu, Kaida Jiang, et al.. (2016). Alterations of microRNA-124 expression in peripheral blood mononuclear cells in pre- and post-treatment patients with major depressive disorder. Journal of Psychiatric Research. 78. 65–71. 79 indexed citations
14.
Qiao, Ying, Lei Zhang, Shen He, et al.. (2016). Plasma metabonomics study of first-Episode schizophrenia treated with olanzapine in female patients. Neuroscience Letters. 617. 270–276. 15 indexed citations
15.
Cao, Jun, Huafang Li, Tiantian Li, et al.. (2015). Identification and Characterization of Lipase Activity and Immunogenicity of LipL from Mycobacterium tuberculosis. PLoS ONE. 10(9). e0138151–e0138151. 24 indexed citations
16.
Shen, He, Tianhong Zhang, Bo Hong, et al.. (2014). Decreased serum fibroblast growth factor - 2 levels in pre- and post-treatment patients with major depressive disorder. Neuroscience Letters. 579. 168–172. 34 indexed citations
17.
Fu, Yingmei, Shunying Yu, Xiaoyun Guo, et al.. (2012). Fluvoxamine increased glutamate release by activating both 5-HT3 and sigma-1 receptors in prelimbic cortex of chronic restraint stress C57BL/6 mice. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1823(4). 826–837. 15 indexed citations
18.
Zhang, Hongyan, et al.. (2011). Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia. SHILAP Revista de lepidopterología.
19.
Wei, Zhiyun, Lei Wang, Jiekun Xuan, et al.. (2009). Association analysis of serotonin receptor 7 gene (HTR7) and risperidone response in Chinese schizophrenia patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 33(3). 547–551. 18 indexed citations
20.
Wu, Shengnan, Rui Gao, Qinghe Xing, et al.. (2006). Association of DRD2 polymorphisms and chlorpromazine-induced extrapyramidal syndrome in Chinese schizophrenic patients1. Acta Pharmacologica Sinica. 27(8). 966–970. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chang‐Uk Lee Breakdown of academic impact, for papers by Lishu Zhang Breakdown of academic impact, for papers by Dongdong Qin Breakdown of academic impact, for papers by Yasuhisa Sakurai Breakdown of academic impact, for papers by Samuel Law Breakdown of academic impact, for papers by Yingdong Zhang Breakdown of academic impact, for papers by Éric Fréchette Breakdown of academic impact, for papers by Yue Lan Breakdown of academic impact, for papers by Xinglong Yang Breakdown of academic impact, for papers by Xianglan Liu
Rankless by CCL
2026